Particle.news

Senate Examines Amendment to Reauthorize Neonicotinoid Acétamipride

The proposal would allow temporary, derogatory use of the insecticide to protect yields and tests whether policy will favor short‑term farm competitiveness over environmental and health safeguards.

Overview

  • Senators began debating an emergency agricultural bill that includes an amendment from LR senator Laurent Duplomb to reauthorize acétamipride on a derogatory basis, with the vote scheduled for Monday, June 29, 2026.
  • Major farming organizations and sugar‑beet producers back the amendment and say access to acétamipride would help fight aphid‑borne diseases and restore competitiveness with neighboring countries that still use the product.
  • Researchers, toxicologists and medical bodies strongly oppose the reintroduction, citing evidence of harm to pollinators, wide environmental contamination and potential human health risks such as endocrine and reproductive toxicity.
  • INRAE’s long‑running Rés0pest trials show pesticide‑free cropping with synthetic fertilizers can reach about 80–85% of local average yields but carry higher year‑to‑year variability and would need public subsidies and industry buy‑in to scale.
  • A prior attempt to reintroduce acétamipride was struck down by the Conseil constitutionnel in August 2025 after mass public opposition, a legal and civic precedent that could shape how the Senate vote and public reaction unfold and that may affect the emergency law’s final adoption.